Qiaoli Peng
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Case reports: Pulmonary destructive lesions caused by ankylosing spondylitis.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: April 22, 2026
Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.
Journal: The Journal of infectious diseases
Published: February 12, 2026
Impact of Different Integrase Strand Transfer Inhibitors on Body Mass Index Among People With HIV Who Newly Started Antiretroviral Therapy in Shenzhen, China: A Real-World Data Analysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 19, 2025
Metabolomic and transcriptomic features of the cardiometabolic disease spectrum in people living with HIV.
Journal: Infectious diseases & immunity
Published: December 08, 2024
Isoformic PD-1 impedes B cell activation and function in HIV-1 infection.
Journal: Cell reports
Published: October 04, 2024
Immune correlates with disease severity in older patients after SARS-CoV-2 BA.2 infection in Hong Kong.
Journal: Clinical immunology (Orlando, Fla.)
Published: December 05, 2023
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study.
Journal: Chinese medical journal
Published: January 31, 2023
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong.
Journal: The Lancet regional health. Western Pacific
Published: October 23, 2022
Monkeypox claims new victims: the outbreak in men who have sex with men.
Journal: Infectious diseases of poverty
Published: June 20, 2022
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
Journal: Journal of virology
Published: March 17, 2022
Last Updated: 09/26/2026